Abstract | OVERVIEW: METHODS:
RNA was isolated from gray matter of brain samples with pathology-defined DLB, AD, AD + DLB, and low-pathology controls, with n = 52 cases initially included (n = 23 with DLB), all with low (<4 h) postmortem intervals. RNA was profiled using Exiqon miRNA microarrays. Quantitative PCR for post hoc replication was performed on separate cases (n = 6 controls) and included RNA isolated from gray matter of MO, AC, primary somatosensory (BA 3), and dorsolateral prefrontal (BA 9) cortical regions. RESULTS: The miRNA expression patterns differed substantially according to anatomic location: of the relatively highly-expressed miRNAs, 150/481 (31%) showed expression that was different between AC versus MO (at p < .05 following correction for multiple comparisons), most (79%) with higher expression in MO. A subset of these results were confirmed in qPCR validation focusing on miR-7, miR-153, miR-133b, miR-137, and miR-34a. No significant variation in miRNA expression was detected in association with either neuropathology or sex after correction for multiple comparisons. CONCLUSION: A subset of miRNAs (some previously associated with α- synucleinopathy and/or directly targeting α- synuclein mRNA) were differentially expressed in AC and MO, which may help explain why these brain regions show differences in vulnerability to Lewy body pathology.
|
Authors | Peter T Nelson, Wang-Xia Wang, Sarah A Janse, Katherine L Thompson |
Journal | Brain research
(Brain Res)
Vol. 1678
Pg. 374-383
(Jan 01 2018)
ISSN: 1872-6240 [Electronic] Netherlands |
PMID | 29146111
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Female
- Gyrus Cinguli
(metabolism)
- Humans
- Lewy Body Disease
(pathology)
- Male
- MicroRNAs
(genetics, metabolism)
- Microarray Analysis
- Motor Cortex
(metabolism)
- RNA, Messenger
(metabolism)
|